Vermont’s Prescribed Products Gift Ban and Disclosures Act - pharmacytimes.com
Vermont's new law prohibits the gifting of prescribed products and mandates disclosures regarding such gifts; non-compliance could lead to penalties.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All pharmaceutical manufacturers and pharmacies operating in Vermont. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate compliance required upon enactment of the law.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Introduction of a ban on gifts related to prescribed products and new disclosure requirements.
Who it affects
All pharmaceutical manufacturers and pharmacies operating in Vermont.
What you must do
Review and update compliance protocols to ensure no gifts are offered and that all required disclosures are made.
Deadline
Immediate compliance required upon enactment of the law.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- The FDA just cleared the way for drug importation. What now? - politico.com
- EPA names BD, Edwards and Medtronic on list of higher-risk sterilization facilities - MedTech Dive
- COVID-19 vaccines may be harder to get in Kentucky under new FDA guidelines. Here's why - The Courier-Journal
- Greek national indicted for selling counterfeit and unapproved prescription drugs to internet pharmacies and undercover agents - justice.gov
- Pfizer Kansas plant hit by FDA 483 with 8 repeat observations - bioprocessintl.com